Anteris Technologies, a medtech firm pursuing approval for a new minimally invasive heart valve, has raised $88 million in an initial public offering of stock, snapping Minnesota’s years-long IPO ...

The JenaValve Trilogy™ Heart Valve System device is used to treat symptomatic severe ... cardiac transplantation and mechanical circulatory support at New York-Presbyterian, and chair and national ...

In a new review article scientists summarize the current ... the researchers observed diseases such as hypertension, obesity and valvular heart disease (such as mitral valve stenosis and mitral valve ...

An 8-year-old Indiana girl will celebrate the holidays at home following a seven-month stay in the hospital after receiving a new heart in a real-life Christmas miracle.

Capstan Medical has raised $110m to advance its robotic platform for cardiac disease treatment in one of the larger medtech ...

The human heart beats 60-100 times a minute, without you needing to pay any attention to it. Heart function is controlled by ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

A new study has found that microRNAs (miRNAs)—cellular RNA fragments that regulate gene expression—can be useful in ...

Capstan Medical Inc. closed an oversubscribed series C fundraising round that brought in $110 million for the structural heart-focused company. Capstan aims to combine valve implants, advanced ...

Scientists at Queen Mary University of London and Barts Health have developed an innovative tool that simulates blood flow in ...

Capstan Medical is developing a surgical robot and catheter-delivered cardiac implants for mitral and tricuspid heart valve ...